Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDIV × Myasthenia Gravis × blinatumomab × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

Tacrolimus 2 Pyridostigmine Bromide 2 Prednisone 2 blinatumomab 1 Steroids 1 Mycophenolic Acid 1 Methylprednisolone 1 Methotrexate 1 Immunosuppressive Agents 1 Immunoglobulins, Intravenous 1 Cyclosporine 1 Cyclophosphamide 1 Azathioprine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06836973 2025-03-25

Blinatumomab for Treatment of Refractory Myasthenia Gravis

Da, Yuwei, M.D.

Phase 2/3 Not yet recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡